# A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants

> **NCT07448155** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Incyte Corporation** · enrollment: 72 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** INCA033989

## Key facts

- **NCT ID:** NCT07448155
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-03-19
- **Primary completion:** 2026-05-23
- **Final completion:** 2026-05-23
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448155, "A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07448155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*